SYDNEY: AI and Medical Technology company Echo IQ Limited announced the appointment of Mr. Kimber Rothwell as Chief Executive Officer, effective 29 January 2024.
Kimber joins Echo IQ with an extensive background in healthcare technology. Most recently he was Vice-President Asia Pacific at Change Healthcare, part of the United Healthcare group of companies (NYSE:UNH) which ranks 10th on the Fortune Global 500.
Prior to Change Healthcare, Kimber held leadership roles at McKesson (NYSE: MCK) (one of the world’s largest healthcare IT vendors and pharmaceutical distributors), Helix Health and
worked with PwC, a market leading professional services firm.
Executive Chair and interim Managing Director, Andrew Grover, will relinquish his role as interim MD upon Mr. Rothwell’s commencement, remaining as Chairman of the Company.
Andrew Grover said “We are delighted to have secured a CEO of Kimber’s calibre and experience to lead Echo IQ through the next phase of growth and development.
His reputation for strategic leadership in healthcare technologies is highly regarded as is his extensive network of industry experts and influencers.
Echo IQ has made significant progress in the past two years with the development of a commercially-ready AI-backed decision support tool for cardiology.
Customer sales have commenced and FDA clearance (anticipated in the coming months) is expected to open up a range of new opportunities where Kimber’s deep
sector experience and expertise will be invaluable to the Company.”